176 related articles for article (PubMed ID: 35443089)
1. Parallel-reaction monitoring revealed altered expression of a number of epitranscriptomic reader, writer, and eraser proteins accompanied with colorectal cancer metastasis.
Qi TF; Tang F; Yin J; Miao W; Wang Y
Proteomics; 2023 Feb; 23(3-4):e2200059. PubMed ID: 35443089
[TBL] [Abstract][Full Text] [Related]
2. Targeted Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Accompanied with Radioresistance in Breast Cancer Cells.
Qi TF; Miao W; Wang Y
Anal Chem; 2022 Jan; 94(3):1525-1530. PubMed ID: 35021009
[TBL] [Abstract][Full Text] [Related]
3. Targeted Quantitative Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Using Stable Isotope-Labeled Peptides.
Qi TF; Liu X; Tang F; Yin J; Yu K; Wang Y
Anal Chem; 2022 Sep; 94(37):12559-12564. PubMed ID: 36084281
[No Abstract] [Full Text] [Related]
4. Targeted Quantitative Proteomic Approach for Probing Altered Protein Expression of Small GTPases Associated with Colorectal Cancer Metastasis.
Huang M; Wang Y
Anal Chem; 2019 May; 91(9):6233-6241. PubMed ID: 30943010
[TBL] [Abstract][Full Text] [Related]
5. Temporal Profiling of Epitranscriptomic Modulators during Osteogenic Differentiation of Human Embryonic Stem Cells.
Yin J; Qi TF; Yang YY; Vera-Colón M; Zur Nieden NI; Wang Y
J Proteome Res; 2023 Jul; 22(7):2179-2185. PubMed ID: 37348120
[TBL] [Abstract][Full Text] [Related]
6. Targeted Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Regulated by H3K36me3.
Yin J; Qi TF; Li L; Wang Y
Anal Chem; 2023 Jun; 95(25):9672-9679. PubMed ID: 37296074
[TBL] [Abstract][Full Text] [Related]
7. Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells.
Lei Y; Huang K; Gao C; Lau QC; Pan H; Xie K; Li J; Liu R; Zhang T; Xie N; Nai HS; Wu H; Dong Q; Zhao X; Nice EC; Huang C; Wei Y
Mol Cell Proteomics; 2011 Oct; 10(10):M110.005397. PubMed ID: 21622897
[TBL] [Abstract][Full Text] [Related]
8. Targeted Quantitative Kinome Analysis Identifies PRPS2 as a Promoter for Colorectal Cancer Metastasis.
Miao W; Wang Y
J Proteome Res; 2019 May; 18(5):2279-2286. PubMed ID: 30908912
[TBL] [Abstract][Full Text] [Related]
9. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.
Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q
J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069
[TBL] [Abstract][Full Text] [Related]
10. Identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells.
Lee JG; McKinney KQ; Pavlopoulos AJ; Park JH; Hwang S
J Proteomics; 2015 Jan; 113():326-36. PubMed ID: 25451013
[TBL] [Abstract][Full Text] [Related]
11. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
Qu LJ; Ding YQ; Liang L
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
[TBL] [Abstract][Full Text] [Related]
12. Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis.
Torres S; Garcia-Palmero I; Bartolomé RA; Fernandez-Aceñero MJ; Molina E; Calviño E; Segura MF; Casal JI
J Pathol; 2017 May; 242(1):39-51. PubMed ID: 28054337
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.
Chung S; Dwabe S; Elshimali Y; Sukhija H; Aroh C; Vadgama JV
PLoS One; 2015; 10(8):e0134948. PubMed ID: 26258407
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional silencing of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon cancer cell line SW620.
Li Q; Chen H
Clin Exp Metastasis; 2011 Feb; 28(2):127-35. PubMed ID: 21184144
[TBL] [Abstract][Full Text] [Related]
15. Spatial Proteomic Analysis of Isogenic Metastatic Colorectal Cancer Cells Reveals Key Dysregulated Proteins Associated with Lymph Node, Liver, and Lung Metastasis.
Solís-Fernández G; Montero-Calle A; Martínez-Useros J; López-Janeiro Á; de Los Ríos V; Sanz R; Dziakova J; Milagrosa E; Fernández-Aceñero MJ; Peláez-García A; Casal JI; Hofkens J; Rocha S; Barderas R
Cells; 2022 Jan; 11(3):. PubMed ID: 35159257
[TBL] [Abstract][Full Text] [Related]
16. The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer.
Baker AM; Cox TR; Bird D; Lang G; Murray GI; Sun XF; Southall SM; Wilson JR; Erler JT
J Natl Cancer Inst; 2011 Mar; 103(5):407-24. PubMed ID: 21282564
[TBL] [Abstract][Full Text] [Related]
17. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
Li Y; Sun Z; Liu B; Shan Y; Zhao L; Jia L
Cell Death Dis; 2017 Jun; 8(6):e2892. PubMed ID: 28640257
[TBL] [Abstract][Full Text] [Related]
18. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment.
Zeng X; Yang P; Chen B; Jin X; Liu Y; Zhao X; Liang S
J Proteomics; 2013 Aug; 89():51-70. PubMed ID: 23748022
[TBL] [Abstract][Full Text] [Related]
19. Targeted Quantitative Profiling of GTP-Binding Proteins in Cancer Cells Using Isotope-Coded GTP Probes.
Cai R; Huang M; Wang Y
Anal Chem; 2018 Dec; 90(24):14339-14346. PubMed ID: 30433760
[TBL] [Abstract][Full Text] [Related]
20. miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.
Zheng YB; Luo HP; Shi Q; Hao ZN; Ding Y; Wang QS; Li SB; Xiao GC; Tong SL
World J Gastroenterol; 2014 Jun; 20(21):6515-22. PubMed ID: 24914372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
